about
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin bindingDAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor statusPhosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoERbeta in breast cancer--onlooker, passive player, or active protector?Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesionsGenome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.Insufficient antibody validation challenges oestrogen receptor beta research.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogensDifferential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.Involvement of estrogen receptor beta in terminal differentiation of mammary gland epitheliumEstrogen receptor β ligands: recent advances and biomedical applications.Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2(-/-) female mice with lipodystrophy.The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target.Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutantPathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors.Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer.TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.Therapeutic significance of estrogen receptor β agonists in gliomas.Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.Oestrogen receptors in breast cancer: basic mechanisms and clinical implications.Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathwaySex hormone receptor repertoire in breast cancer.Characterization of the ERbeta-/-mouse heart.Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsFulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.Antiestrogenic Activity of Triptolide in Human Breast Cancer Cells MCF-7 and Immature Female Mouse.MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio.Aromatase inhibitors and other novel agents in breast cancer treatment.
P2860
Q24647300-9148EC7E-DE47-4A97-8156-6606045FD46EQ24794574-3208680B-A410-4EA7-804B-50562BA149F1Q24813594-F239A35B-FC7B-4A0C-BF7F-F6C650C274FCQ27302901-295959FB-1B52-48E1-9DE0-99F4FC8BDB8EQ30438399-75BB7D16-E59C-4EDC-B445-FD526829EB32Q33562282-1399F615-EC04-47D7-A0EB-CB86EA624639Q33576510-1E370121-2F4B-4139-85B9-D0A35DF059D1Q33885342-B508BE4C-5E45-49DF-B1CD-5CE32553145FQ33903965-20CF9012-64CF-4E47-B247-274FC91F7550Q34320280-8450043A-E5BF-43B7-B5F0-3F166E91750CQ34332592-B809208F-0E1C-4F5E-B173-4C18DA8409FEQ34387983-3CAE0FE9-CA7A-4262-9750-E5CECE0AC138Q35016384-84E4310B-58B1-40BD-ACFB-0904AE6F6F86Q35572298-5459421E-525A-4D52-9799-121146084A37Q35587582-658D2F5F-7CF5-4734-8A6C-BCE19E1EDDD1Q35712301-F0C8654F-EDCF-42AB-8BF3-6E8FF7129E82Q35750078-C9D685A9-79EC-4F24-AA8A-73190BC560A4Q36160032-C8C9E38D-6AEB-4195-A7A3-1F20BA63CE58Q36301166-90BF3919-3693-4E6C-BA8E-D21B9B77813CQ36497287-8A66484F-893B-452B-A47D-9A38384CEB94Q36841629-03B8FE64-1894-4198-B35B-2D703177C1ACQ36848788-23CC0C4B-E8B0-40FA-A654-BEEB1AEF04F0Q36936984-09FE7C85-D718-4E7D-BB59-68E3876A5B50Q37000743-A57FAE63-8805-4782-82F0-048E5101AF45Q37039582-E6058C3E-A8DF-4FA3-97EE-D915962510A1Q37094546-6A497D15-F79F-4BEA-82E6-36CEBD9B54EBQ37277124-0D9601BC-355D-428F-8829-4EE3FC059141Q37277897-2FB02217-1F08-46B5-BB44-C6CA242290F9Q37325301-A8CA8A6F-5005-4C76-A23F-F1C48E609E5BQ37353645-B039624A-8410-4644-AB13-A66C9253358BQ37557518-51779CFE-1A6D-45C5-826E-92A9DC9C7D2EQ37571359-AD869FF0-9AD7-46CF-9F28-1670EBAF981DQ37624907-0DEEE46D-79CA-45BF-BD7B-F111AAA8E986Q37636714-7154E7D4-8079-49FB-8F8A-510E87213AE1Q38299171-9AECFCB0-05E0-4401-90CF-412DE702280EQ38700487-E1CBB764-E602-43B5-A9E4-22993E42EBD8Q39173393-39ACA184-2EB7-4AF0-9C58-823C8EB1B4DAQ39344606-F900EE6A-8E2C-4042-A45C-D8A07DBC7ED9Q39380396-2A4E8540-BDD8-4BE5-9F7D-152BF7177328Q40409345-2CF4D6B4-BA5D-42BC-AD27-61745B56B51E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Estrogen receptor beta in breast cancer.
@ast
Estrogen receptor beta in breast cancer.
@en
Estrogen receptor beta in breast cancer.
@nl
type
label
Estrogen receptor beta in breast cancer.
@ast
Estrogen receptor beta in breast cancer.
@en
Estrogen receptor beta in breast cancer.
@nl
prefLabel
Estrogen receptor beta in breast cancer.
@ast
Estrogen receptor beta in breast cancer.
@en
Estrogen receptor beta in breast cancer.
@nl
P2093
P356
P1476
Estrogen receptor beta in breast cancer
@en
P2093
C Palmieri
J-A Gustafsson
M Zelada-Hedman
R C Coombes
S Van Noorden
T Wahlstrom
P356
10.1677/ERC.0.0090001
P577
2002-03-01T00:00:00Z